MYELOFIBROSIS (MF)

Clinical trials for MYELOFIBROSIS (MF) explained in plain language.

Never miss a new study

Get alerted when new MYELOFIBROSIS (MF) trials appear

Sign up with your email to follow new studies for MYELOFIBROSIS (MF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 6 Not yet finished but already full! 1 Completed 3

New hope for rare blood cancer: drug duo targets enlarged spleen

Disease control Ongoing

This study tests whether adding the experimental drug navitoclax to the standard drug ruxolitinib can shrink the spleen and reduce symptoms better than other available treatments in adults with myelofibrosis that has returned or not improved. About 330 participants will be random…

Matched conditions: MYELOFIBROSIS (MF)

Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

MYELOFIBROSIS (MF)

Get alerted when new MYELOFIBROSIS (MF) trials appear

New hope for rare blood cancer: drug duo targets enlarged spleen